Delivery Order SPE2DB20D2002-SPE2DB23FL18J
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,647.40 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,583.62, is a Firm Fixed Price Delivery Order for the MENVEO vaccine. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.48, is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The award has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $3,216.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the MENVEO VACCINE VL 5S pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this contract without any set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,224.50 firm-fixed-price delivery order is for the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with an ultimate completion date of May 30, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,528.75 firm fixed price delivery order supports the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has a completion date of September 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $125,928.00, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a period of performance through March 3, 2025. The contract does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,328.76, is a firm fixed-price delivery order to supply the MENVEO VACCINE VL 5S. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $5,189.11 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccination product. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,122.83 firm fixed-price delivery order is for the supply of MENVEO A-C-Y-W kits (2 vials) and has an ultimate completion date of May 6, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a wide range...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL18JDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,489.15, is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract is a firm fixed-price Delivery Order with a period of performance through February 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 2/8/23 |